Omega Diagnostics Group PLC PDMR/Director Dealing (1870O)
June 08 2022 - 8:48AM
UK Regulatory
TIDMODX
RNS Number : 1870O
Omega Diagnostics Group PLC
08 June 2022
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
PDMR/Director Dealing
Omega (AIM: ODX), the specialist medical diagnostics company
focused on industry-leading Health & Nutrition and Global
Health products, announces that, following the general meeting held
on 6 June 2022 and Admission on 8 June 2022, the following
Directors participated in the Fundraising and their resultant
holdings are detailed in the table below.
Director Board Position Number of Amount (GBP) Resultant Resultant
Subscription holding percentage
Shares at holding of
the Issue Enlarged
Price Issued Share
Capital
Simon Douglas(1) Chairman 500,000 2 0,000 500,000 0.21%
---------------- -------------- ------------- ---------- --------------
Jag Grewal(2) CEO 500,000 20,000 735,746 0.31%
---------------- -------------- ------------- ---------- --------------
Chris Lea(3) CFO 500,000 20,000 500,000 0.21%
---------------- -------------- ------------- ---------- --------------
Non-Executive
Jeremy Millard(4) Director 500,000 20,000 1,025,000 0.43%
---------------- -------------- ------------- ---------- --------------
Capitalised terms not otherwise defined in the text of this
announcement have the meanings given to them in the Company's
circular dated 13 May 2022.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate
Finance)
Alice Lane/ Harriet Ward (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro
diagnostic products for use in hospitals, clinics, laboratories and
healthcare practitioners in over 70 countries and specialise in the
areas of health and nutrition and global health.
www.omegadx.com
Notification of transactions of persons discharging managerial
responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name 1) Simon Douglas
2) Jag Grewal
3) Chris Lea
4) Jeremy Millard
---------------------------- ----------------------------------
2 Reason for the notification
----------------------------------------------------------------
a) Position/status 1) Chairman
2) Chief Executive Officer
3) Chief Financial Officer
4) Non-Executive Director
---------------------------- ----------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------------- ----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name Omega Diagnostics Group Plc
---------------------------- ----------------------------------
b) LEI 2138007U9P4BTZTYIR92
---------------------------- ----------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
----------------------------------------------------------------
a) Description of Ordinary Shares of 4 pence each
the financial instrument,
type of instrument ISIN: GB00B1VCP282
Identification
code
---------------------------- ----------------------------------
b) Nature of the transaction Purchase of Shares
---------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
1) GBP0.04 500,000
2) GBP0.04 500,000
3) GBP0.04 500,000
4) GBP0.04 500,000
---------------------------- ----------------------------------
d) Aggregated information N/A - single transaction for
-Aggregated volume each Director or PCA
- Price
---------------------------- ----------------------------------
e) Date of the transaction 6 May 2022
---------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange (AIM)
---------------------------- ----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBKFBQBBKDAAK
(END) Dow Jones Newswires
June 08, 2022 08:48 ET (12:48 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Sep 2023 to Sep 2024